All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
B7-33 (6mg) is a synthetic peptide compound studied in laboratory environments for its interaction with relaxin-family peptide receptor signaling pathways. In experimental research models, B7-33 has been investigated for its potential role in cellular communication networks associated with tissue remodeling, inflammatory signaling pathways, and extracellular matrix regulation. This formulation is supplied strictly for controlled laboratory research applications focused on receptor signaling biology and cellular structural regulation systems.
Relaxin-related signaling pathways play an important role in regulating tissue elasticity, cellular communication, and extracellular matrix dynamics. Researchers studying connective tissue biology frequently examine compounds that interact with relaxin-family receptors in order to better understand how tissues respond to stress, inflammation, and remodeling signals.
B7-33 (6mg) – Research Specifications:
| Compound | B7-33 |
| Quantity | 6mg per vial |
| Compound Type | Synthetic peptide studied for relaxin receptor signaling |
| Purity / Identity | Research-grade; refer to Certificate of Analysis (COA) for lot-specific analytical verification |
| Appearance | Lyophilized peptide powder |
| Storage Conditions | Store sealed in a cool, dry environment protected from heat, light, and moisture |
| Research Use Only | Supplied exclusively for laboratory research use. Not for human consumption. |
B7-33 is a synthetic peptide derived from the relaxin hormone family and has been studied in laboratory environments for its interaction with the relaxin family peptide receptor 1 (RXFP1). This receptor signaling system is involved in multiple biological pathways associated with tissue remodeling, cellular communication, and extracellular matrix regulation.
The extracellular matrix provides structural support for tissues and plays an important role in regulating cellular behavior and signaling. Researchers studying connective tissue biology frequently investigate compounds capable of influencing matrix remodeling pathways to better understand tissue repair and structural regulation mechanisms.
Laboratory studies examining relaxin signaling pathways often intersect with broader research into inflammatory signaling, fibrosis-related pathways, and cellular stress responses. B7-33 has therefore been investigated in experimental models examining receptor signaling pathways associated with tissue structural regulation.
Important Research Notice: Nordsci research materials are supported by lot-specific analytical documentation. Certificates of Analysis are available for laboratories requiring verification of compound identity and analytical quality standards.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR CONDITION.
Relaxin-family receptors coordinate signaling pathways associated with tissue remodeling and cellular communication. Laboratory studies may investigate how B7-33 interacts with relaxin receptor pathways involved in connective tissue regulation.
The extracellular matrix is responsible for providing structural support and regulating cellular signaling environments. Experimental research programs may explore how peptide signaling compounds interact with pathways involved in matrix remodeling and tissue structural stability.
Tissue remodeling involves coordinated biochemical signaling that regulates structural adaptation within tissues. Researchers may evaluate how receptor-signaling peptides influence pathways associated with tissue structural regulation and remodeling processes.
Inflammation is regulated through complex cellular signaling systems that coordinate immune responses and tissue repair processes. Laboratory models may examine how peptide signaling compounds interact with inflammatory regulatory pathways within tissue environments.
B7-33 (6mg) should be handled according to established laboratory procedures used for peptide research materials. Proper storage conditions, environmental controls, and documentation of experimental variables help support reliable and reproducible outcomes in receptor signaling research programs.
Protocol Design Considerations: Tissue signaling research may be influenced by variables including oxidative stress exposure, inflammatory baseline conditions, metabolic activity, and environmental stress factors. Researchers should maintain strict experimental controls when designing studies involving receptor signaling peptides.
Note: The information above is provided strictly for laboratory research reference purposes. All experiments should be conducted by qualified personnel within appropriate laboratory environments.
Each lot of B7-33 supplied by Nordsci Peptides includes a Certificate of Analysis confirming compound identity and analytical purity verification. These reports support laboratory documentation standards and traceability requirements within controlled research programs.
Laboratories sourcing peptide compounds typically prioritize analytical transparency, batch traceability, and consistent manufacturing standards. Nordsci Peptides supplies research-grade peptide compounds supported by analytical verification designed to support reliable laboratory research workflows.
IMPORTANT: B7-33 (6mg) is supplied exclusively for laboratory research use. It is not approved for human consumption or therapeutic use. Researchers are responsible for ensuring compliance with all applicable institutional and regulatory guidelines governing research materials.
